Literature DB >> 11420669

Functional analysis and intracellular localization of p53 modified by SUMO-1.

S S Kwek1, J Derry, A L Tyner, Z Shen, A V Gudkov.   

Abstract

p53 tumor suppressor is a subject of several post-translational modifications, including phosphorylation, ubiquitination and acetylation, which regulate p53 function. A new covalent modification of p53 at lysine 386 by SUMO-1 was recently identified. To elucidate the function of sumoylated p53, we compared the properties of wild type p53 and sumoylation-deficient p53 mutant, K386R. No differences were found between wild type p53 and K386R mutant of p53 in transactivation or growth suppression assays. Moreover, overexpression of SUMO-1 has no effect on p53-regulated transcription. Biochemical fractionation showed that sumoylated p53 is localized in the nucleus and is tightly bound to chromatin structures. p53 and SUMO-1 co-localized in PML nuclear bodies in 293 cells and the nucleoli in MCF7 and HT1080 cells. However, sumoylation-deficient p53 mutant showed a similar pattern of intranuclear localization, suggesting that SUMO-1 does not target p53 to subnuclear structures. These data indicate that SUMO-1 modification of p53 at lysine 386 may not be essential for p53's cellular localization, transcriptional activation, or growth regulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420669     DOI: 10.1038/sj.onc.1204362

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

1.  PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies.

Authors:  S Sachdev; L Bruhn; H Sieber; A Pichler; F Melchior; R Grosschedl
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

2.  Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.

Authors:  Darja Schmidt; Stefan Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

3.  Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function.

Authors:  Shih-Shun Chen; Pi-Chu Chang; Yu-Wen Cheng; Fen-Mei Tang; Young-Sun Lin
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

4.  Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc finger proteins, and nuclear pore complex proteins: a proteomic analysis.

Authors:  Tianwei Li; Evgenij Evdokimov; Rong-Fong Shen; Chien-Chung Chao; Ephrem Tekle; Tao Wang; Earl R Stadtman; David C H Yang; P Boon Chock
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-25       Impact factor: 11.205

Review 5.  The p53 orchestra: Mdm2 and Mdmx set the tone.

Authors:  Mark Wade; Yunyuan V Wang; Geoffrey M Wahl
Journal:  Trends Cell Biol       Date:  2010-02-19       Impact factor: 20.808

6.  Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding.

Authors:  Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  EMBO J       Date:  2009-04-02       Impact factor: 11.598

7.  SUMOylation of p53 mediates interferon activities.

Authors:  Laura Marcos-Villar; José V Pérez-Girón; Jéssica M Vilas; Atenea Soto; Carlos F de la Cruz-Hererra; Valerie Lang; Manuel Collado; Anxo Vidal; Manuel S Rodríguez; César Muñoz-Fontela; Carmen Rivas
Journal:  Cell Cycle       Date:  2013-08-05       Impact factor: 4.534

8.  PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73.

Authors:  Eliana Munarriz; Daniela Barcaroli; Anastasis Stephanou; Paul A Townsend; Carine Maisse; Alessandro Terrinoni; Michael H Neale; Seamus J Martin; David S Latchman; Richard A Knight; Gerry Melino; Vincenzo De Laurenzi
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

9.  p53 sumoylation: mechanistic insights from reconstitution studies.

Authors:  Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  Epigenetics       Date:  2009-10-09       Impact factor: 4.528

10.  PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.

Authors:  Lisa Ivanschitz; Yuki Takahashi; Florence Jollivet; Olivier Ayrault; Morgane Le Bras; Hugues de Thé
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.